Completely revised and updated, the second edition of this classic text retains its predecessor's careful balance of theory and practice while incorporating new approaches, more data sets, and a broader scope. Enhancements in this edition include a new chapter on bioequivalence, methods for analyzing longitudinal continuous and categorical data, extensive real-life examples, and SAS code that allows readers to implement the analyses described. With downloadable SAS programs, thorough treatment of design issues, and a comprehensive catalog of designs, this edition sets a new standard for texts in this area and will undoubtedly be of direct practical value for years to come.
Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.
Descrizione libro Chapman and Hall/CRC, 1989. Hardcover. Condizione libro: New. Codice libro della libreria DADAX0412300001
Descrizione libro Chapman and Hall/CRC, 1989. Condizione libro: New. Brand New, Unread Copy in Perfect Condition. A+ Customer Service! Summary: Pharmaceutical companies throughout the world invest enormous resources in drug development and testing. The cross-over trial is an important type of trial in which each subject acts as its own control, leading to more accurate treatment comparisons. Given the high cost of clinical trials, the effective use of resources is vital and this requires a sound appreciation of the statistical issues in the design and analysis of cross-over trials. Codice libro della libreria ABE_book_new_0412300001
Descrizione libro Chapman and Hall/CRC, 1989. Hardcover. Condizione libro: New. book. Codice libro della libreria 0412300001